TherapeuticsMD, Inc. (TXMD)
2.21
-0.03
(-1.34%)
USD |
NASDAQ |
Sep 04, 16:00
2.17
-0.04
(-1.81%)
After-Hours: 20:00
TherapeuticsMD Debt to Equity Ratio : 0.2049 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2049 |
| March 31, 2026 | 0.2162 |
| December 31, 2025 | 0.2269 |
| September 30, 2025 | 0.2362 |
| June 30, 2025 | 0.242 |
| March 31, 2025 | 0.2607 |
| December 31, 2024 | 0.2621 |
| September 30, 2024 | 0.2731 |
| June 30, 2024 | 0.2744 |
| March 31, 2024 | 0.2722 |
| December 31, 2023 | 0.2733 |
| September 30, 2023 | 0.2925 |
| June 30, 2023 | 0.2688 |
| March 31, 2023 | 0.2678 |
| September 30, 2022 | -2.532 |
| June 30, 2022 | -3.832 |
| March 31, 2022 | -1.509 |
| December 31, 2021 | -2.112 |
| September 30, 2021 | -3.399 |
| June 30, 2021 | -3.946 |
| March 31, 2021 | -20.31 |
| December 31, 2020 | -2.005 |
| September 30, 2020 | -2.140 |
| June 30, 2020 | -2.712 |
| March 31, 2020 | -5.618 |
| Date | Value |
|---|---|
| December 31, 2019 | 22.31 |
| September 30, 2019 | -9.662 |
| June 30, 2019 | 24.43 |
| March 31, 2019 | 1.275 |
| December 31, 2018 | 0.7524 |
| September 30, 2018 | 0.5458 |
| June 30, 2018 | 0.9432 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 37.53M |
| Total Liabilities (Quarterly) | 10.40M |
| Shareholders Equity (Quarterly) | 27.13M |
| Current Ratio | 2.756 |
| Net Debt Paydown Yield | 1.10% |